SS Innovations Reports Record Q1 2026 Revenue, Driven by Surgical Robotics Expansion

SS Innovations International Inc. (NASDAQ: SSII) reported record first-quarter 2026 financial results, with revenue reaching $11.1 million, a 116.8% increase year over year. The growth was driven primarily by higher installations of the company's SSi Mantra surgical robotic system and increased procedure volumes. Gross profit rose to $5.3 million from $1.1 million in the same period last year, underscoring the company's expanding commercial footprint.

As of the end of Q1 2026, the installed base of SSi Mantra systems reached 194 across 11 countries, with nearly 9,750 cumulative robotic procedures completed. The company also secured regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines during the quarter, broadening its international market access. These approvals are critical for SS Innovations as it aims to penetrate emerging healthcare markets where demand for advanced surgical technology is growing.

In a landmark achievement, SS Innovations completed the world's longest-distance robotic cardiac telesurgery, demonstrating the capabilities of its remote surgery platform. This milestone highlights the potential of telesurgery to bridge geographic gaps in healthcare delivery, enabling patients in remote areas to access specialized surgical expertise.

The company continues to pursue regulatory clearance in both the United States and Europe, which would open the largest healthcare markets globally. The expansion into these regions could significantly accelerate adoption of the SSi Mantra system and drive further revenue growth.

As of June 22, 2026, the cumulative number of multi-specialty procedures performed with the SSi Mantra system totaled 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the system, which has been used for over 170 different types of procedures. This broad applicability positions the SSi Mantra as a versatile tool for hospitals seeking to enhance surgical capabilities.

The implications of SS Innovations' growth extend beyond the company's financial performance. By expanding access to robotic surgery in emerging markets and advancing telesurgery technology, the company is contributing to a shift in how surgical care is delivered globally. For the healthcare industry, this could mean reduced disparities in access to high-quality surgical procedures, particularly in underserved regions. For investors, the strong revenue growth and expanding installed base signal increasing commercial traction and potential for long-term value creation.

For more information, visit the company's website at www.SSInnovations.com.